Evidence map›Paper›PMID 34203240›Full record

ReviewCells2021

Application of Stem Cell Therapy for Infertility.

Sarama Saha, Partha Roy, Cynthia Corbitt, Sham S Kakar

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Utilization of Stem Cells in Medicine: A Narrative Review.International journal of molecular sciences · 2025
    Review
  8. Review
  9. CRL2BMC biology · 2025
    Article
  10. Recent Trends in the Management of Varicocele.Journal of clinical medicine · 2025
    Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Testicular immunity.Molecular aspects of medicine · 2024
    Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Sarama SahaDepartment of Biochemistry, All India Institute of Medical Sciences, Rishikesh 249203, India.ORCID 0000-0002-7838-9875
Partha RoyDepartment of Biotechnology, Indian Institute of Technology, Roorkee 247667, India.
Cynthia CorbittDepartment of Biology, University of Louisville, Louisville, KY 40292, USA.
Sham S KakarDepartment of Physiology and James Graham Brown Cancer Center, University of Louisville, Louisville, KY 40292, USA.
University of Louisville · USAll India Institute of Medical Sciences Rishikesh · INIndian Institute of Technology Roorkee · IN

Funding

Current Trends in Stem Cell TherapiesT32HL134644 · NHLBI · UNIVERSITY OF LOUISVILLE · PI KAKAR, SHAM S., RATAJCZAK, MARIUSZ Z · 2017 to 2021
$1.4M
National Institute of Health R25 GM1333328NIH HHS T32 HL134644
6 · The paper itself

Abstract

Infertility creates an immense impact on the psychosocial wellbeing of affected couples, leading to poor quality of life. Infertility is now considered to be a global health issue affecting approximately 15% of couples worldwide. It may arise from factors related to the male (30%), including varicocele, undescended testes, testicular cancer, and azoospermia; the female (30%), including premature ovarian failure and uterine disorders; or both partners (30%). With the recent advancement in assisted reproduction technology (ART), many affected couples (80%) could find a solution. However, a substantial number of couples cannot conceive even after ART. Stem cells are now increasingly being investigated as promising alternative therapeutics in translational research of regenerative medicine. Tremendous headway has been made to understand the biology and function of stem cells. Considering the minimum ethical concern and easily available abundant resources, extensive research is being conducted on induced pluripotent stem cells (iPSCs) and mesenchymal stem cells (MSC) for their potential application in reproductive medicine, especially in cases of infertility resulting from azoospermia and premature ovarian insufficiency. However, most of these investigations have been carried out in animal models. Evolutionary divergence observed in pluripotency among animals and humans requires caution when extrapolating the data obtained from murine models to safely apply them to clinical applications in humans. Hence, more clinical trials based on larger populations need to be carried out to investigate the relevance of stem cell therapy, including its safety and efficacy, in translational infertility medicine.

Indexed as

AnimalsClinical Trials as TopicHumansInfertilityReproductive Techniques, AssistedRisk FactorsStem Cell TransplantationSyndromeassisted reproduction technologyinduced pluripotent stem cellinfertilitymesenchymal stem cellspermatogonial stem cell

Identifiers

PMID34203240
PMCPMC8303590
OpenAlexW3174318272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.